News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
216,785 Results
Type
Article (12066)
Company Profile (112)
Press Release (204607)
Multimedia
Podcasts (7)
Webinars (9)
Section
Business (59853)
Career Advice (416)
Deals (9292)
Drug Delivery (21)
Drug Development (30856)
Employer Resources (43)
FDA (3755)
Job Trends (4888)
News (102084)
Policy (8178)
Tag
Academia (980)
Accelerated approval (1)
Adcomms (5)
Allergies (27)
Alliances (16850)
ALS (33)
Alzheimer's disease (496)
Antibody-drug conjugate (ADC) (37)
Approvals (3769)
Artificial intelligence (88)
Autoimmune disease (13)
Automation (5)
Bankruptcy (70)
Best Places to Work (4185)
BIOSECURE Act (14)
Biosimilars (18)
Biotechnology (94)
Bladder cancer (28)
Brain cancer (9)
Breast cancer (93)
Cancer (848)
Cardiovascular disease (27)
Career advice (381)
Career pathing (7)
CAR-T (84)
Cell therapy (247)
Cervical cancer (8)
Clinical research (23602)
Collaboration (368)
Compensation (145)
Complete response letters (5)
COVID-19 (2206)
CRISPR (26)
C-suite (130)
Cystic fibrosis (47)
Data (929)
Denatured (1)
Depression (12)
Diabetes (74)
Diagnostics (1837)
Digital health (9)
Diversity (1)
Diversity, equity & inclusion (14)
Drug discovery (56)
Drug pricing (12)
Drug shortages (3)
Duchenne muscular dystrophy (34)
Earnings (19444)
Editorial (9)
Employer branding (4)
Employer resources (38)
Events (45731)
Executive appointments (331)
FDA (4198)
Friedreich's ataxia (2)
Frontotemporal dementia (7)
Funding (300)
Gene editing (56)
Generative AI (7)
Gene therapy (190)
GLP-1 (187)
Government (1621)
Guidances (56)
Healthcare (5338)
Huntington's disease (9)
IgA nephropathy (12)
Immunology and inflammation (40)
Indications (13)
Infectious disease (2327)
Inflammatory bowel disease (62)
Inflation Reduction Act (1)
Influenza (52)
Intellectual property (43)
Interviews (55)
IPO (4694)
IRA (6)
Job creations (908)
Job search strategy (340)
Kidney cancer (2)
Labor market (15)
Layoffs (82)
Legal (1338)
Liver cancer (27)
Lung cancer (75)
Lymphoma (79)
Machine learning (2)
Management (12)
Manufacturing (126)
MASH (24)
Medical device (2267)
Medtech (2267)
Mergers & acquisitions (4856)
Metabolic disorders (184)
Multiple sclerosis (41)
NASH (1)
Neurodegenerative disease (25)
Neuropsychiatric disorders (4)
Neuroscience (677)
NextGen: Class of 2025 (1606)
Non-profit (1226)
Now hiring (11)
Obesity (88)
Opinion (63)
Ovarian cancer (37)
Pain (33)
Pancreatic cancer (51)
Parkinson's disease (52)
Partnered (6)
Patents (89)
Patient recruitment (43)
Peanut (18)
People (21105)
Pharmaceutical (20)
Phase I (8711)
Phase II (11080)
Phase III (6725)
Pipeline (564)
Policy (37)
Postmarket research (575)
Preclinical (4095)
Press Release (54)
Prostate cancer (32)
Psychedelics (5)
Radiopharmaceuticals (61)
Rare diseases (111)
Real estate (1891)
Recruiting (20)
Regulatory (5910)
Reports (16)
Research institute (829)
Resumes & cover letters (42)
Rett syndrome (2)
RNA editing (2)
RSV (48)
Schizophrenia (15)
Series A (51)
Series B (40)
Service/supplier (4)
Sickle cell disease (14)
Special edition (2)
Spinal muscular atrophy (52)
Sponsored (10)
Startups (1298)
State (1)
Stomach cancer (2)
Supply chain (22)
Tariffs (11)
The Weekly (5)
Vaccines (512)
Venture capitalists (7)
Weight loss (39)
Women's health (5)
Worklife (4)
Date
Today (80)
Last 7 days (393)
Last 30 days (1204)
Last 365 days (12685)
2025 (4601)
2024 (13575)
2023 (15078)
2022 (21221)
2021 (26949)
2020 (24460)
2019 (11269)
2018 (8686)
2017 (8750)
2016 (8375)
2015 (9434)
2014 (7256)
2013 (5915)
2012 (6449)
2011 (7131)
2010 (6527)
Location
Africa (303)
Alabama (35)
Alaska (1)
Arizona (44)
Arkansas (7)
Asia (12631)
Australia (2806)
California (2659)
Canada (784)
China (144)
Colorado (63)
Connecticut (111)
Delaware (54)
Europe (29202)
Florida (328)
Georgia (47)
Idaho (21)
Illinois (180)
India (6)
Indiana (130)
Iowa (2)
Japan (54)
Kansas (21)
Kentucky (5)
Louisiana (5)
Maine (8)
Maryland (364)
Massachusetts (2040)
Michigan (91)
Minnesota (114)
Mississippi (1)
Missouri (21)
Montana (9)
Nebraska (9)
Nevada (14)
New Hampshire (8)
New Jersey (691)
New Mexico (9)
New York (684)
North Carolina (414)
North Dakota (5)
Northern California (1180)
Ohio (77)
Oklahoma (7)
Oregon (7)
Pennsylvania (603)
Puerto Rico (5)
Rhode Island (7)
South America (369)
South Carolina (4)
Southern California (1027)
Tennessee (19)
Texas (385)
United States (9392)
Utah (37)
Virginia (74)
Washington D.C. (15)
Washington State (367)
West Virginia (3)
Wisconsin (10)
216,785 Results for "vir biotechnology".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Vir Biotechnology Provides Corporate Update and Reports First Quarter 2025 Financial Results
May 8, 2025
·
17 min read
Leadership
Vir Leans Into Immunology Roots After Flamed-Out COVID Fame
Just a few months after Vir Biotechnology lost an emergency authorization for its COVID-19 antibody, Marianne de Backer stepped in as CEO to answer a critical question: What’s next?
February 12, 2025
·
5 min read
·
Annalee Armstrong
Press Releases
Vir Biotechnology to Provide Corporate Update and Report First Quarter 2025 Financial Results on May 7, 2025
April 30, 2025
·
1 min read
Press Releases
Vir Biotechnology Announces Preliminary 24-Week Post-End of Treatment Data for Tobevibart and Elebsiran Combinations in Chronic Hepatitis B From the MARCH Study
May 9, 2025
·
9 min read
Press Releases
Vir Biotechnology to Present Latest Clinical Data in Hepatitis Delta and B Programs at the European Association for the Study of the Liver (EASL) Congress 2025
April 24, 2025
·
6 min read
Press Releases
Vir Biotechnology Enrolls First Patient in Phase 3 ECLIPSE Registrational Program for Chronic Hepatitis Delta
March 13, 2025
·
9 min read
Press Releases
Vir Biotechnology to Participate in TD Cowen 45th Annual Health Care Conference
February 19, 2025
·
1 min read
Press Releases
Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2024 Financial Results
February 27, 2025
·
20 min read
Biotech Bay
Vir Biotechnology to Host 2024 Annual Meeting of Stockholders
Vir Biotechnology, Inc. (Nasdaq: VIR) today reminds stockholders that it will hold its 2024 Annual Meeting of Stockholders on Wednesday, May 29, 2024, at 9:00 a.m. PT.
May 23, 2024
·
1 min read
Press Releases
Vir Biotechnology Announces Encouraging Safety and Efficacy Data in Ongoing Dose Escalation Trials for Dual Masked T-Cell Engagers VIR-5818 in Solid Tumors and VIR-5500 in mCRPC
January 8, 2025
·
10 min read
1 of 21,679
Next
